Selegiline Capsule

Selegiline capsules function as a selective irreversible MAO-B inhibitor that provides essential therapeutic synergy by preventing the breakdown of dopamine, thereby significantly augmenting the efficacy and duration of levodopa therapy. By stabilizing dopamine concentrations within the nigrostriatal pathway, this formulation effectively mitigates motor fluctuations and reduces “off” episodes for patients experiencing a declining response to standard Parkinson’s treatments. The capsule delivery system ensures precise dosing and optimal ingredient stability, providing a reliable pharmacokinetic profile that facilitates consistent systemic absorption and improved patient adherence.